Income Tax Department Imposes Rs 57.74 Crore Penalties on Emcure Pharmaceuticals for Seven Financial Years:

Emcure Pharmaceuticals faces a total Rs 57.74 crore income tax penalty for FY2014-15 to FY2020-21 and is evaluating legal options to appeal the orders.
Emcure Pharma Faces Rs 57.74 Cr Tax Penalty

Emcure Pharmaceuticals Limited has received multiple orders from the Income Tax Department for financial years 2014-15 to 2020-21 imposing a total penalty of Rs 57.74 crore.
The company revealed the development in a filing to the stock exchanges on October 2, 2026. The penalties relate to assessment years 2015-16 to 2021-22 and are linked to ongoing tax litigation which Emcure had earlier disclosed.
The orders were passed by the Deputy Commissioner of Income Tax, Central Circle 2(1), Pune, the company said. The lawsuit was filed on December 27, 2023.
Emcure said that it is examining its legal options and may file an appeal before the Appellate Authority against the orders.
The company has disclosed the ongoing litigation in its Integrated Governance Reports, the latest disclosure relating to the quarter ended June 30, 2026.
The latest orders cover a period of seven years, FY2014-15 to FY2020-21, and the total penalty comes to Rs 57,73,96,732.
About Author
Vanshika verma
Content Writer
Studycafe
Delhi, Delhi, India
2187My Recent Articles
- B.Tech Biotechnology in Delhi NCR: Exploring The Curriculum, College Facilities and Career Prospects
- What Can You Trade During Muhurat Trading 2026? Stocks, ETFs, F&O and MTF Explained
- Bharti Airtel Receives Rs 1.07 Lakh Penalty Notice From DoT Maharashtra Over Alleged Subscriber Verification Violations
- Rashi Peripherals Faces Rs 2.15 Crore Customs Duty and Penalty Demand Over Alleged Misclassification of Imported Goods, Considers CESTAT Appeal
- High-Profile Birthday Party at Rajkot's Saraza Hotel Raided by LCB; Prominent Industrialists and Business Leaders Under Scanner
Loading suggestions…
Recent Posts
All Posts
Recent Posts
All Posts










